Third Trimester definition

Third Trimester means one of the following three distinct periods of time in the duration of a pregnancy:
Sample 1Sample 2Sample 3
Third Trimester means the weeks of pregnancy after the 24th week of pregnancy.
Sample 1Sample 2
Third Trimester means the stage of pregnancy that begins at the end of the 26th week from the beginning of the pregnant woman's last menstrual period.
Sample 1Sample 2

Examples of Third Trimester in a sentence

  • Full year Strings 6 2 Band 7 (full year) Band 7 Band 7 3 Band 8 (full year) Band 8 Band 8 4 Orchestra 7/8 (full year) Orchestra 7/8 Orchestra 7/8 5 Strings 6 (full year) Strings 6 Strings 6 5 preps 5 preps 5 preps Vocal Music Teacher Period First Trimester Second Trimester Third Trimester Count 1 Choir 6 (full year) Choir 6 Choir 6 6 preps this year 1.

  • Full year Strategic Reading 24 week 24 week 2 Spanish 7 Spanish 7 Spanish 6 3 Spanish 6 Spanish 6 Spanish 6 4 Spanish 8 Spanish 8 Spanish 7 24 week 24 week 5 Strategic Reading Strategic Reading Strategic Reading (full year) (full year) (full year) 4 preps 4 preps 3 preps Math Teacher Period First Trimester Second Trimester Third Trimester Count 1 Algebra I Algebra I Algebra I 3 preps this year 1.

  • If an expectant mother is diagnosed with any one of the covered pregnancy complicationsStill Birth in the Third Trimester Pre-eclampsia or Eclampsia Placental AbruptionPlacenta Accreta or Placenta Increta# Amniotic Fluid Embolism#Acute Fatty Liver of PregnancyDisseminated Intravascular Coagulation of Pregnancy Postpartum Haemorrhage requiring Hysterectomy## Surgery must have been performed to treat the condition while this benefit is in effect.

  • Graduation of students whose names are included in the lists submitted by the following Constituent Universities, who have completed all the requirements for their respective degrees/titles as of the end of Third Trimester and Mid-Year Term AY 2017-2018, or as of the end of term specified, and recommended by their respective University Councils:…………………………………………...

  • Computer Applications 8 2 Technology 7 Technology 7 Technology 7 3 Technology 8 Technology 8 Technology 8 4 Computer Applications 6 Computer Applications 6 Computer Applications 6 5 Computer Applications 7 Computer Applications 7 Computer Applications 8 5 preps 5 preps 5 preps Spanish Teacher Period First Trimester Second Trimester Third Trimester Count 1 Spanish 8 Spanish 8 Spanish 7 4 preps this year 1.

  • TrimestersThe Centers for Disease Control and Prevention (CDC) defines a trimester as a term of three months in the prenatal gestation period with the specific trimesters defined as follows in weeks:First Trimester: 0-13 weeks Second Trimester: 14-26 weeks Third Trimester: 27-40 weeks Further, CDC begins the calculation of weeks starting with the first day of the last menstrual period.

  • Anti-TNF-alpha Use During the Third Trimester of Pregnancy in Women with Moderate-severe Inflammatory Bowel Disease and the Risk of Preterm Birth and Low Birth Weight.

  • Sometimes due to delay in admission formalities, if the First trimester (for fresh students) is delayed by few days, the subsequent Second and Third Trimester may be correspondingly delayed.

  • Maternal Dietary Patterns during Third Trimester in Association with Birthweight Characteristics and Early Infant Growth.

  • Behavioral and Academic Expectations for Student Council Officers:Students who wish to run for office must have a minimum of B average overall (for ALL classes including Specials for the previous Trimester) and must submit two letters of recommendation to the Council Advisors from adults who are not their Parent(s)/Guardian(s) of the candidate.* Third Trimester grades will be used in determining eligibility for participation during the Fall.


More Definitions of Third Trimester

Third Trimester means one of the following
Sample 1Sample 2
Third Trimester means one of the following three
Sample 1

Related to Third Trimester

  • Phase III Trial means a human Clinical Trial of the Licensed Product, which trial is designed (a) to establish that the Licensed Product is safe and efficacious for its intended use; (b) to define warnings, precautions and adverse reactions that are associated with the Licensed Product in the dosage range to be prescribed; and (c) consistent with 21 CFR § 312.21(c).

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Phase III Study means a human clinical trial that is prospectively designed to demonstrate statistically whether a product is safe and effective for use in humans in a manner sufficient to obtain regulatory approval to market such product in patients having the disease or condition being studied as described in 21 C.F.R. § 312.21(c) (FDCA), as amended from time to time, and the foreign equivalent thereof.

  • Field trip means any experience a child has away from the premises of the center, while under the care of center staff, whether a child walks or is transported.

  • Pivotal Clinical Trial means a pivotal human clinical trial of a Licensed Product with a defined dose or a set of defined doses of such Licensed Product designed to ascertain efficacy and safety of such Licensed Product for the purpose of enabling the preparation and submission of an MAA to the competent Regulatory Authorities in a country of the Territory, as further defined in 21 C.F.R. § 312.21(c) for the U.S., as amended from time to time, or the corresponding foreign regulations.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • Clinical evaluation means a systematic and planned process to continuously generate, collect, analyse and assess the clinical data pertaining to a device in order to verify the safety and performance, including clinical benefits, of the device when used as intended by the manufacturer;

  • Phase III Clinical Trial means a large, controlled or uncontrolled Clinical Study that would satisfy the requirements of 21 CFR 312.21(c), intended to gather the additional information about effectiveness and safety that is needed to evaluate the overall benefit-risk relationship of the drug and to provide an adequate basis for physician labeling.

  • clinical evidence means clinical data and clinical evaluation results pertaining to a device of a sufficient amount and quality to allow a qualified assessment of whether the device is safe and achieves the intended clinical benefit(s), when used as intended by the manufacturer;

  • Genetic testing means an analysis of genetic markers to exclude or identify a man as the father or a woman as the mother of a child. The term includes an analysis of one or a combination of the following:

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Phase I Study means a study in humans which provides for the first introduction into humans of a product, conducted in healthy volunteers or patients to obtain information on product safety, tolerability, pharmacological activity or pharmacokinetics, as more fully defined in 21 C.F.R. § 312.21(a) (or the non-United States equivalent thereof).

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.

  • Genetic test means an analysis of human DNA, RNA, chromosomes, proteins, or metabolites, that detect genotypes, mutations, or chromosomal changes. The term “genetic test” does not mean an analysis of proteins or metabolites that does not detect genotypes, mutations, or chromosomal changes; or an analysis of proteins or metabolites that is directly related to a manifested disease, disorder, or pathological condition that could reasonably be detected by a health care professional with appropriate training and expertise in the field of medicine involved.

  • Phase II Trial means a clinical trial of a Licensed Product on patients, including possibly pharmacokinetic and dose ranging studies, the principal purposes of which are to make a preliminary determination that such Licensed Product is safe for its intended use and to obtain sufficient information about such Licensed Product’s efficacy to permit the design of further clinical trials, and generally consistent with 21 CFR §312.21(b), or its successor regulation, or the equivalent in any foreign country.

  • Phase I Trial means a clinical trial of a Licensed Product in human patients conducted primarily for the purpose of determining the safety, tolerability and preliminary activity of the Licensed Product, including, without limitation, for determining the maximum tolerated dose, or optimal dose. For purposes of this Agreement, a Phase I trial shall specifically exclude a study in healthy volunteers.

  • Phase I Clinical Study means, as to a particular Licensed Product, an initial clinical study in humans with the purpose of assessing the Licensed Product’s safety, tolerability, toxicity, pharmacokinetics or other pharmacological properties.

  • Phase 3 Trial means a human clinical trial of a Product on a sufficient number of subjects that is designed to establish that a pharmaceutical product is safe and efficacious for its intended use, and to determine warnings, precautions and adverse reactions that are associated with such pharmaceutical product in the dosage range to be prescribed, which trial is intended to support Approval of a Product, as described in 21 C.F.R. 312.21(c) for the United States, or a similar clinical study prescribed by the Regulatory Authorities in a foreign country.

  • Commercial Launch means on a country-by-country basis, the first sale of a Product to a Third Party following Regulatory Approval of the Product in such country.

  • Therapeutic diet means meals served that are soft, low-fat, low-sodium or controlled calorie.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Phase II Clinical Study means a human clinical study of a product initiated to determine the safety and efficacy in the target patient population, as described 21 C.F.R. 312.21(b).

  • Phase I Clinical Trial means a study in humans which provides for the first introduction into humans of a product, conducted in normal volunteers or patients to generate information on product safety, tolerability, pharmacological activity or pharmacokinetics, or otherwise consistent with the requirements of U.S. 21 C.F.R. §312.21(a) or its foreign equivalents.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Milestone Event has the meaning set forth in Section 8.4.

  • Phase 2 Trial means a human clinical trial conducted on study subjects with the disease or condition being studied for the principal purpose of achieving a preliminary determination of efficacy or appropriate dosage ranges, as further described in 21 C.F.R. §312.21(b) (including any such clinical study in any country other than the United States).